Quest Diagnostics is Thursday's IBD Stock Of The Day. Shares are lingering in a buy zone, helped by a Texas court's ruling ...

Quest Diagnostics Inc. closed 4.61% short of its 52-week high of $178.87, which the company reached on March 10th.

Quest Diagnostics Incorporated's ( NYSE:DGX ) dividend will be increasing from last year's payment of the same ...

The most recent lawsuit is from winter 2024, when the California attorney general announced a $5 million settlement with ...

Wrapping up Q4 earnings, we look at the numbers and key takeaways for the testing & diagnostics services stocks, including ...

Quest Diagnostics (NYSE: DGX), a leader in diagnostic information services, today announced a new solution aimed at broadening access to human papillomavirus (HPV) screening to help identify women who ...

Redburn Atlantic analyst Jamie Clark initiated coverage of Quest Diagnostics (DGX) with a Buy rating and $195 price target Don't Miss Our End ...

Dozens of healthcare providers descended on the Legislative Office Building Thursday, with a united message: increase ...

Quest Diagnostics teamed up with Google Cloud. The collaboration seeks to deliver new AI capabilities — including predictive ...

B, consensus $10.78B. Sees cash provided by operations $1.45B, and Capital expenditures $500M. For the Q1, the company now expects that worse-than-anticipated weather during the period will create a ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

This was the stock's second consecutive day of gains.